Literature DB >> 7687082

Role of peptide growth factors in the prostate: a review.

M S Steiner1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 7687082     DOI： 10.1016/0090-4295(93)90352-b

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  17 in total

1.  Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma.

Authors:  S B Shappell; S Manning; W E Boeglin; Y F Guan; R L Roberts; L Davis; S J Olson; G S Jack; C S Coffey; T M Wheeler; M D Breyer; A R Brash
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

2.  Effect of dexamethasone and testosterone treatment on the regulation of insulin-degrading enzyme and cellular changes in ventral rat prostate after castration.

Authors:  Juliany S B César Vieira; Karina L A Saraiva; Maria C L Barbosa; Regina C C Porto; Juan C Cresto; Christina A Peixoto; Maria I Wanderley; Daniel P Udrisar
Journal:  Int J Exp Pathol       Date:  2011-04-21       Impact factor: 1.925

3.  Bone morphogenetic protein-6 expression in normal and malignant prostate.

Authors:  J Barnes; C T Anthony; N Wall; M S Steiner
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 4.  Regulation of prostate growth by fibroblast growth factors.

Authors:  M T Story
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 5.  Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk.

Authors:  Mitchell S Steiner; Sharan Raghow
Journal:  World J Urol       Date:  2003-02-14       Impact factor: 4.226

6.  Stat3 promotes metastatic progression of prostate cancer.

Authors:  Junaid Abdulghani; Lei Gu; Ayush Dagvadorj; Jacqueline Lutz; Benjamin Leiby; Gloria Bonuccelli; Michael P Lisanti; Tobias Zellweger; Kalle Alanen; Tuomas Mirtti; Tapio Visakorpi; Lukas Bubendorf; Marja T Nevalainen
Journal:  Am J Pathol       Date:  2008-05-15       Impact factor: 4.307

Review 7.  Immunopathological prognostic and predictive factors in prostate cancer.

Authors:  E Sivridis; S Touloupidis; A Giatromanolaki
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

8.  Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1.

Authors:  S W Hayward; R Dahiya; G R Cunha; J Bartek; N Deshpande; P Narayan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

9.  Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.

Authors:  P A Humphrey; X Zhu; R Zarnegar; P E Swanson; T L Ratliff; R T Vollmer; M L Day
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

10.  Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610.

Authors:  Larry Pan; Seunghee Baek; Pamela R Edmonds; Mack Roach; Harvey Wolkov; Satish Shah; Alan Pollack; M Elizabeth Hammond; Adam P Dicker
Journal:  Radiat Oncol       Date:  2013-04-25       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.